Abstract
Disclosed are methods of treating cystic fibrosis using AmB and a sterol or compositions comprising AmB and a sterol. Also disclosed are methods of increasing the pH of airway surface liquid in a patient having cystic fibrosis using AmB and a sterol; and methods of decreasing the viscosity of airway surface liquid in a patient having cystic fibrosis using AmB and a sterol.
Original language | English (US) |
---|---|
U.S. patent number | 12090164 |
Filing date | 10/11/18 |
State | Published - Sep 17 2024 |